Join the club for FREE to access the whole archive and other member benefits.

Christin Glorioso

Founder and CEO at NeuroAge Therapeutics and Founder and Executive Director at Longevity SF

Physician-scientist and serial entrepreneur with expertise in neuroscience and computational modeling. I have more than 15 years of research experience focused on aging clocks in human brain, which forms the basis of my longevity techbio company, NeuroAge Therapeutics. NeuroAge is a finalist in the US National Institute of Aging Startup Challenge and recipient of the Illumina sequencing grant. I am passionate community building and am the Founder and Executive Director of Longevity SF, which connects longevity researchers, investors, and entrepreneurs in the SF Bay Area and in NYC. I was previously Chief Strategist of the Bakar Aging Research Institute at UCSF, Community Building Chair of the MIT Postdoc Association, and Graduate Student Body President.

Visit website: https://drglorioso.substack.com/about

 christin-glorioso-md-phd-39627719

 DrGlorioso

See also: Company NeuroAge Therapeutics - Longevity pharmatech that creates drugs to rejuvenate biological brain aging and treat neurodegenerative disorders

Details last updated 27-Dec-2022

Christin Glorioso is also referenced in the following:

The Longevity Summit 2024

03-Dec-2024 to 04-Dec-2024

Longevity researchers, investors, and entrepreneurs speaking about eliminating disease of ageing by Longevity Global (Novato, CA, USA)